CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
Standard Genetic Counseling +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04245176
NCT04245176N/ACompleted
CompareCT.gov

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Brigham and Women's Hospital·interventional·Posted Jan 28, 2020·Updated May 4, 2026

In Brief

A clinical study evaluating Standard Genetic Counseling and Quantitative Genetic Counseling for Breast Cancer and 3 related conditions. Completed, enrolled 400 participants across 1 site.

Detailed Summary

This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer This research study involves an expedited and surgery-specific form of genetic counseling. The names of the study methods involved in this trial are/is: * Quantitative genetic counseling (discussion is guided by tables and graphs) * Standard genetic counseling

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Genetic Testing
CountriesUnited States
CollaboratorsMyriad Genetics, Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 28, 2020
Enrollment StartJan 31, 2020
Primary CompletionDec 1, 2025
Study CompletionJan 1, 2026
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 6.4 years ago

Interventions

Standard Genetic Counselingbehavioral

Standard genetic counseling: Standard of care discussion

Quantitative Genetic Counselingbehavioral

Quantitative genetic counseling: Discussion is guided by tables and graphs.